Relief Therapeutics (Switzerland) Investor Sentiment

RLF Stock  CHF 3.90  0.08  2.01%   
Slightly above 66% of Relief Therapeutics' investor base is looking to short. The analysis of current outlook of investing in Relief Therapeutics Holding suggests that many traders are alarmed regarding Relief Therapeutics' prospects. Relief Therapeutics' investing sentiment can be driven by a variety of factors including economic data, Relief Therapeutics' earnings reports, geopolitical events, and overall market trends.
Relief Therapeutics stock news, alerts, and headlines are usually related to its technical, predictive, social, and fundamental indicators. It can reflect on the current distribution of Relief daily returns and investor perception about the current price of Relief Therapeutics Holding as well as its diversification or hedging effects on your existing portfolios.
  
over a month ago at news.google.com         
Relief Therapeutics To Merge With US Biotech Renexxion - Law360
Google News at Macroaxis
over two months ago at news.google.com         
Investors bid Relief Therapeutics Holding up CHF20m despite increasing losses YoY, taking five-year ...
Google News at Macroaxis
over two months ago at news.google.com         
Tonix Pharmaceuticals Announces Data Presentations on TNX-102 SL for Fibromyalgia at the 11th Global...
Google News at Macroaxis
over two months ago at news.google.com         
Relief Therapeutics Completes Clinical Phase in RLF-OD032 Proof-of-Concept Study Topline Results Exp...
Google News at Macroaxis
over three months ago at news.google.com         
Were Interested To See How Relief Therapeutics Holding Uses Its Cash Hoard To Grow - Yahoo Finance U...
Google News at Macroaxis
over three months ago at news.google.com         
Relief Therapeutics Announces PKU GOLIKE Study Results Presentation at SSIEM 2024 - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
TNXP - Tonix Pharmaceuticals Holding Corp. Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over three months ago at news.google.com         
Relief Therapeutics Shares Down 9 percent - Defense World
Google News at Macroaxis
over three months ago at news.google.com         
TNXP - Tonix Pharmaceuticals Holding Corp. Latest Stock News Market Updates - StockTitan
Google News at Macroaxis
over three months ago at news.google.com         
RELIEF THERAPEUTICS Holding SA Announces Results of Annual General Meeting - Yahoo Finance
Google News at Macroaxis
over three months ago at news.google.com         
Acer Therapeutics and Relief Therapeutics Announce Presentation of ACER-001 Data at the Society for ...
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics Announces Notice of Annual General Meeting of Shareholders - Yahoo Canada Financ...
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics Announces New Executive Leadership Team Strengthening Capabilities to Guide the ...
Google News at Macroaxis
over six months ago at news.google.com         
Relief Therapeutics has Published its Annual Report - Yahoo Finance
Google News at Macroaxis
over six months ago at news.google.com         
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting - Yahoo Finance
Google News at Macroaxis
Far too much social signal, news, headlines, and media speculation about Relief Therapeutics that are available to investors today. That information is available publicly through Relief media outlets and privately through word of mouth or via Relief internal channels. However, regardless of the origin, that massive amount of Relief data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of Relief Therapeutics news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of Relief Therapeutics relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to Relief Therapeutics' headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive Relief Therapeutics alpha.

Relief Therapeutics Performance against Dow Jones

 Price Growth (%)  
       Timeline  

Additional Tools for Relief Stock Analysis

When running Relief Therapeutics' price analysis, check to measure Relief Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Relief Therapeutics is operating at the current time. Most of Relief Therapeutics' value examination focuses on studying past and present price action to predict the probability of Relief Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Relief Therapeutics' price. Additionally, you may evaluate how the addition of Relief Therapeutics to your portfolios can decrease your overall portfolio volatility.